Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 249.10
Bid: 249.90
Ask: 250.00
Change: -4.40 (-1.74%)
Spread: 0.10 (0.04%)
Open: 253.40
High: 253.50
Low: 249.10
Prev. Close: 253.50
LGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pension Risk Transfer Transaction

6 Jun 2019 07:00

RNS Number : 2989B
Legal & General Group Plc
06 June 2019
 

Legal & General announces largest UK bulk annuity with Rolls-Royce UK Pension Fund

Legal & General Group Plc announces that the business ("Legal & General") has written a pension risk transfer ("PRT") transaction in excess of £4.6 billion with the Rolls-Royce UK Pension Fund ("RRPF"), covering approximately 33,000 in-payment pensioners.

 

This is the largest bulk annuity written in the UK and, including this, Legal & General has now transacted four of the five largest UK PRT deals, namely, British Airways (£4.4 billion), ICI (£3.0 billion) and TRW (£2.5 billion).

 

Legal & General has a long standing relationship with Rolls-Royce, having provided investment management services to the pension plan since 1989. In 2016, Legal & General issued a £1.1bn buyout for the Vickers Group Pension Scheme. Legal & General will continue to provide investment management services for a significant proportion of RRPF's remaining £8.4 billion asset portfolio following today's transaction.

 

In aggregate, Legal & General has transacted over £6.2 billion of global PRT year to date (H1 2018: £0.7bn). The financial metrics and Solvency II capital strain of these deals are in line with previous transactions.

 

Nigel Wilson, Chief Executive, Legal & General, said:

"The Rolls-Royce transaction again demonstrates our extensive strengths and synergies. We have a unique combination of pension, actuarial and structuring expertise coupled with the capacity to create and source long-term direct investments at scale. The global PRT opportunity remains sizeable and compelling: only 8% of the £2.2 trillion of UK DB pension liabilities and 5% of the $3.5 trillion in the US have completed PRT. Our pipeline and appetite for further transactions in H2 remains strong."

 

Laura Mason, CEO Legal & General Retirement Institutional, said:

"We have developed an excellent relationship over many years with Rolls-Royce, providing both investment and pension de-risking expertise and support. This transaction, which demonstrates the strength and expertise of the Legal & General team, is excellent news for the pension plan and the sponsor. It will provide enhanced security for plan members and the quality customer service for which Legal & General is known."

 

Liz Airey, Chair of Trustees, Rolls-Royce Pension Fund, said:

"The Trustee is delighted to have achieved this outcome for our members. The transaction will provide greater security and certainty around the retirement benefits our members have been promised. This has been made possible by careful risk management over many years and a strong collaboration between the Trustee, Rolls-Royce and our advisers." 

Notes to editors

Legal & General Group Plc

Established in 1836, Legal & General is one of the UK's leading financial services groups and a major global investor, with international businesses in the US, Europe, Middle East and Asia. With over £1 trillion in total assets under management, we are the UK's largest investment manager for corporate pension schemes and a UK market leader in pension risk transfer, life insurance, workplace pensions and retirement income. As at 5 June 2019, Legal & General has a market capitalisation of £15.6 billion.

Legal & General Retirement Insitutional works with trustees and sponsoring companies of Defined Benefit (DB) Pension Schemes to settle their pension obligations and secure scheme members' benefits, through a full range of risk transfer solutions to pension schemes of all sizes.

Forward-looking statements

This announcement may contain certain forward-looking statements relating to Legal & General, its plans and its current goals and expectations relating to future financial condition, performance and results. By their nature, forward-looking statements involve uncertainty because they relate to future events and circumstances which are beyond Legal & General's control, including, among others, UK domestic and global economic and business conditions, market-related risks such as fluctuations in interest rates and exchange rates, the policies and actions of regulatory and Governmental authorities, the impact of competition, the timing impact of these events and other uncertainties of future acquisitions or combinations within relevant industries. As a result, Legal & General's actual future condition, performance and results may differ materially from the plans, goals and expectations set out in these forward-looking statements and persons reading this announcement should not place reliance on forward-looking statements. These forward-looking statements are made only as at the date on which such statements are made and Legal & General does not undertake to update forward-looking statements contained in this announcement or any other forward-looking statement it may make.

 

Further information

Investors

Edward Houghton Head of Investor Relations +44 (0)20 3124 2091

Alyssa Manning Investor Relations Director +44 (0)20 3124 2047

Sujee Rajah Investor Relations Director +1 312 964 3034

 

Media

John Godfrey Corporate Affairs Director +44 (0)20 3124 2090

Margrit Williams PR & Communications Director, Legal & General Retirement +44 (0)20 3128 1299

Graeme Wilson Tulchan Communications +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKPDPCBKDBAK
Date   Source Headline
11th Apr 20236:09 pmRNSDirector/PDMR Shareholding
11th Apr 20235:33 pmRNSDirector/PDMR Shareholding
4th Apr 20235:00 pmRNSDirector/PDMR Shareholding
4th Apr 20235:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:00 pmRNSTotal Voting Rights
15th Mar 202310:00 amRNSAnnual Financial Report
8th Mar 20237:00 amRNSL&G Full Year Results 2022 Part 2
8th Mar 20237:00 amRNSL&G Full Year Results 2022 Part 1
2nd Mar 20235:00 pmRNSDirector/PDMR Shareholding
1st Mar 20235:00 pmRNSDirector/PDMR Shareholding
1st Mar 20235:00 pmRNSDirector/PDMR Shareholding
1st Mar 20235:00 pmRNSTotal Voting Rights
16th Feb 202311:38 amRNSHolding(s) in Company
15th Feb 20231:51 pmRNSHolding(s) in Company
10th Feb 202310:42 amRNSHolding(s) in Company
2nd Feb 20235:00 pmRNSDirector/PDMR Shareholding
1st Feb 20235:00 pmRNSDirector/PDMR Shareholding
1st Feb 20235:00 pmRNSDirector/PDMR Shareholding
1st Feb 20235:00 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSPlanned retirement of Sir Nigel Wilson
23rd Jan 20237:47 amRNSDirector Declaration
4th Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSTotal Voting Rights
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSBlock listing Interim Review
22nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSTotal Voting Rights
29th Nov 20221:50 pmRNSIFRS 17 investor and analyst event
18th Nov 20227:00 amRNSTrading Statement
11th Nov 20229:00 amRNSBoard Committee Appointment
7th Nov 20224:31 pmRNSHolding(s) in Company
2nd Nov 20225:00 pmRNSDirector/PDMR Shareholding
1st Nov 20225:33 pmRNSDirector/PDMR Shareholding
1st Nov 20225:31 pmRNSDirector/PDMR Shareholding
1st Nov 20225:30 pmRNSTotal Voting Rights
14th Oct 20229:00 amRNSBoard Committee Appointment
4th Oct 20225:00 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSTrading Statement
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:00 pmRNSTotal Voting Rights
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.